Cover Image
Market Research Report

Mycoses Market: By Types of Fungi (dermatophytes, yeasts and molds, others), By Treatment (Photodynamic, Radiation, Chemotherapy, Targeted, Others) & By Region-Forecast 2019-2024

Published by IndustryARC Product code 422194
Published Content info
Delivery time: 2-3 business days
Price
Back to Top
Mycoses Market: By Types of Fungi (dermatophytes, yeasts and molds, others), By Treatment (Photodynamic, Radiation, Chemotherapy, Targeted, Others) & By Region-Forecast 2019-2024
Published: December 5, 2018 Content info:
Description

Mycoses surgeries are the root cause of fungal skin infections caused by fungi and primarily caused by three groups of fungi: dermatophytes, yeasts and moldsare. Mycoses are caused due to weakened immune systems, i.e., immunocompromised state that includes patients with HIV/AIDS and patients being treated with corticosteroids for a prolonged period. Globally, increasing prevalence of AIDS/HIV and weakened immune systems, Large Population Base, rising awareness regarding Mycoses, and Recent development in technology are the prime growth drivers of global Mycoses market. In addition, increase in adoption of Mycoses treatment, and emerging economies such as China, India and others, will create new opportunities for global Mycoses market. However, higher cost of the research and development, and risk of side effects are the key restraints for global Mycoses market.

Geographically North America dominated global Mycoses market, with approximately half of the world's procedures being done in the U.S. because of high medical reimbursement facilities, and technological advancement. Europe is projected to have fastest growth, owing to rapidly increasing prevalence AIDS/HIV, leading to weakened commune system, Population's changing life style and environment, and modernization of healthcare infrastructure. Among all the types, Dermatophytes has the highest market share in global Mycoses market due to higher prevalence of low immune patients across the globe.

This report identifies the global Mycoses market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global Mycoses market.

This report segments global Mycoses market on the basis of type of fungi, treatment, and regional market as follows:

Mycoses Market, By Type of Fungi: dermatophytes, yeasts and molds, others

The report has focused study on Mycoses market by basis of treatment such as: Photodynamic, Radiation, Chemotherapy, Targeted, Others

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the Mycoses market. Some of the major companies' profiles in detail are as follows:

Bayer AG

Dr. Reddy's Laboratories Limited

Merck & Co., Inc

Pacgen Biopharmaceuticals Corporation

Quinnova Pharmaceuticals, Inc

Table of Contents

Table of Contents

1. Mycoses Market - Market Overview

2. Executive Summary

3. Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
  • 3.3. Product Benchmarking
  • 3.4. End User Profiling
  • 3.5. Top 5 Financials Analysis

4. Mycoses Market- Market Forces

  • 4.1. Drivers
    • 4.1.1. Increasing prevalence of AIDS/HIV and weakened immune systems
    • 4.1.2. Large Population Base
    • 4.1.3. Recent development in technology
  • 4.2. Restraints
    • 4.2.1. Higher cost of research and development
  • 4.3. Opportunities
    • 4.3.1. Emerging economies
  • 4.4. Challenges
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. Mycoses Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Mycoses Market, By Type of Fungi

  • 6.1. Dermatophytes
  • 6.2. Yeasts
  • 6.3. Molds
  • 6.4. others

7. Mycoses Market, By Treatment

  • 7.1. Photodynamic therapy
  • 7.2. Radiation therapy
  • 7.3. Chemotherapy
  • 7.4. Targeted therapy
  • 7.5. Drug Medication

8. Mycoses Market, By Geography

  • 8.1. Europe
    • 8.1.1. Germany
    • 8.1.2. France
    • 8.1.3. Italy
    • 8.1.4. Spain
    • 8.1.5. Russia
    • 8.1.6. U.K.
    • 8.1.7. Rest of Europe
  • 8.2. Asia Pacific
    • 8.2.1. China
    • 8.2.2. India
    • 8.2.3. Japan
    • 8.2.4. South Korea
    • 8.2.5. Rest of Asia-Pacific
  • 8.3. North America
    • 8.3.1. U.S.
    • 8.3.2. Canada
    • 8.3.3. Mexico
  • 8.4. Rest of the World (RoW)
    • 8.4.1. Brazil
    • 8.4.2. Rest of RoW

9. Mycoses - Market Entropy

  • 9.1. Expansion
  • 9.2. Technological Developments
  • 9.3. Merger & Acquisitions, and Joint Ventures
  • 9.4. Supply- Contract

10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 10.1. Bayer AG
  • 10.2. Dr. Reddy's Laboratories Limited
  • 10.3. Helix BioMedix, Inc
  • 10.4. Merck & Co., Inc
  • 10.5. Pfizer, Inc
  • 10.6. Nuvo Research, Inc
  • 10.7. Moberg Derma AB
  • 10.8. Novabiotics Ltd
  • 10.9. Pacgen Biopharmaceuticals Corporation
  • 10.10. Quinnova Pharmaceuticals, Inc

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

11. Appendix

  • 11.1. Abbreviations
  • 11.2. Sources
  • 11.3. Research Methodology
  • 11.4. Bibliography
  • 11.5. Compilation of Expert Insights
  • 11.6. Disclaimer
Back to Top